Anti-inflammatory properties of lactic acid bacteria producing superoxide dismutase

American Journal of Physiology - Gastrointestinal and Liver Physiology

Volumn 294, Issue 1, 2007, Pages

  Han, Wei ^a   Fioramonti, Jean ^a,b  

^a Neurogastroenterology and Nutrition Unit   (France)

^b CEMAGREF   (France)

Author keywords

[No Author keywords available]

Indexed keywords

SUPEROXIDE DISMUTASE;

ANTIINFLAMMATORY ACTIVITY; BACTERIAL SURVIVAL; COLITIS; ENZYME ANALYSIS; LACTIC ACID BACTERIUM; LETTER; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; COLITIS; COLON; DISEASE MODELS, ANIMAL; INTERLEUKIN-10; LACTOBACILLUS; MICE; MICE, KNOCKOUT; PROBIOTICS; REACTIVE OXYGEN SPECIES; SUPEROXIDE DISMUTASE; TRINITROBENZENESULFONIC ACID;

EID: 38349131639     PISSN: 01931857     EISSN: 15221547     Source Type: Journal    
DOI: 10.1152/ajpgi.00517.2007     Document Type: Letter

References (5)

1. Carroll IM, Andrus JM, Bruno-Barcena JM, Klaenhammer TR, Hassan HM, Threadgill DS. Anti-inflammatory properties of Lactobacillus gasseri expressing manganese superoxide dismutase using the interleukin 10-deficient mouse model of colitis. Am J Physiol Gastrointest Liver Physiol 293: G729-G738, 2007.
2. Han W, Mercenier A, Ait-Belgnaoui A, Pavan S, Lamine F, van Swam I, Kleerebezem M, Salvador-Cartier C, Hisbergues M, Bueno L, Theodorou V, Fioramonti J. Improvement of an experimental colitis in rats by lactic acid bacteria producing superoxide dismutase. Inflamm Bowel Dis 12: 1044-1052, 2006.
3. Kennedy RJ, Hoper M, Deodhar K, Kirk SJ, Gardiner KR. Probiotic therapy fails to improve gut permeability in a hapten model of colitis. Scand J Gastroenterol 35: 1266-1271, 2000.
4. Rochat T, Bermudez-Humaran L, Gratadoux JJ, Fourage C, Hoebler C, Corthier G, Langella P. Anti-inflammatory effects of Lactobacillus casei BL23 producing or not a manganese-dependent catalase on DSS-induced colitis in mice. Microb Cell Fact 6: 22-31, 2007.
5. Schultz M, Veltkamp C, Dieleman LA, Grenther WB, Wyrick PB, Tonkonogy SL, Sartor RB. Lactobacillus plantarum 299V in the treatment and prevention of spontaneous colitis in interleukin-10-deficient mice. Inflamm Bowel Dis 8: 71-80, 2002.